CA2443277A1 - Interferon gamma polypeptide variants - Google Patents

Interferon gamma polypeptide variants Download PDF

Info

Publication number
CA2443277A1
CA2443277A1 CA002443277A CA2443277A CA2443277A1 CA 2443277 A1 CA2443277 A1 CA 2443277A1 CA 002443277 A CA002443277 A CA 002443277A CA 2443277 A CA2443277 A CA 2443277A CA 2443277 A1 CA2443277 A1 CA 2443277A1
Authority
CA
Canada
Prior art keywords
seq
variant
lys
polypeptide
ifng
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002443277A
Other languages
English (en)
French (fr)
Inventor
Anne Dam Jensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen Holdings Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2443277A1 publication Critical patent/CA2443277A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002443277A 2001-04-06 2002-04-04 Interferon gamma polypeptide variants Abandoned CA2443277A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200100579 2001-04-06
DKPA200100579 2001-04-06
DKPA200100714 2001-05-07
DKPA200100714 2001-05-07
DKPA200200198 2002-02-11
DKPA200200198 2002-02-11
PCT/DK2002/000226 WO2002081507A2 (en) 2001-04-06 2002-04-04 Interferon gamma polypeptide variants

Publications (1)

Publication Number Publication Date
CA2443277A1 true CA2443277A1 (en) 2002-10-17

Family

ID=27222504

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002443277A Abandoned CA2443277A1 (en) 2001-04-06 2002-04-04 Interferon gamma polypeptide variants

Country Status (15)

Country Link
EP (1) EP1412382A2 (zh)
JP (1) JP2005518183A (zh)
KR (1) KR20030094336A (zh)
CN (1) CN1257186C (zh)
BG (1) BG108256A (zh)
BR (1) BR0208596A (zh)
CA (1) CA2443277A1 (zh)
HK (1) HK1069834A1 (zh)
HU (1) HUP0303645A3 (zh)
IL (1) IL157896A0 (zh)
MX (1) MXPA03009082A (zh)
NO (1) NO20034432L (zh)
NZ (1) NZ528651A (zh)
PL (1) PL366705A1 (zh)
WO (1) WO2002081507A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023182947A1 (en) * 2022-03-22 2023-09-28 Chiang Mai University A modified protein of interferon gamma and its use thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2390262A1 (en) 2003-05-16 2011-11-30 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
JP4707327B2 (ja) * 2004-01-27 2011-06-22 旭化成ファーマ株式会社 ポリペプタイド類の吸着防止剤
KR20070085227A (ko) * 2004-08-09 2007-08-27 앨리오스 바이오파마 인크. 합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
JP5769142B2 (ja) * 2007-09-04 2015-08-26 独立行政法人酒類総合研究所 ピヒア属酵母において異種タンパク質を高分泌させる方法
EP2039764A1 (en) * 2007-09-19 2009-03-25 Pevion Biotech AG Truncated secretory aspartyl proteinase 2
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
RU2446821C2 (ru) * 2010-07-15 2012-04-10 Олег Ильич Эпштейн Лекарственное средство для лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способ лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями
GB201621728D0 (en) 2016-12-20 2017-02-01 Ucb Biopharma Sprl Methods
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
BG52073B2 (en) * 1990-01-24 1996-04-30 Inst Molekuljarna Biolog Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine
DE4036856C1 (zh) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023182947A1 (en) * 2022-03-22 2023-09-28 Chiang Mai University A modified protein of interferon gamma and its use thereof

Also Published As

Publication number Publication date
CN1257186C (zh) 2006-05-24
NO20034432L (no) 2003-10-29
JP2005518183A (ja) 2005-06-23
BG108256A (bg) 2004-12-30
HK1069834A1 (en) 2005-06-03
HUP0303645A3 (en) 2005-12-28
MXPA03009082A (es) 2004-11-22
WO2002081507A2 (en) 2002-10-17
BR0208596A (pt) 2004-03-09
PL366705A1 (en) 2005-02-07
IL157896A0 (en) 2004-03-28
NO20034432D0 (no) 2003-10-03
WO2002081507A3 (en) 2004-02-12
EP1412382A2 (en) 2004-04-28
HUP0303645A2 (hu) 2004-01-28
NZ528651A (en) 2006-06-30
CN1537117A (zh) 2004-10-13
KR20030094336A (ko) 2003-12-11

Similar Documents

Publication Publication Date Title
US7419805B2 (en) Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression
US7504237B2 (en) Polynucleotides encoding interferon gamma polypeptides
US7390638B2 (en) S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants
WO2002074806A2 (en) New interferon beta-like molecules
US7230081B1 (en) Interferon gamma conjugates
CA2443277A1 (en) Interferon gamma polypeptide variants
WO2001058950A1 (en) Improved interleukin 10
US7524931B2 (en) Full-length interferon gamma polypeptide variants
RU2268749C2 (ru) КОНЪЮГАТЫ γ-ИНТЕРФЕРОНА
AU2002252971B2 (en) Interferon gamma polypeptide variants
RU2296130C2 (ru) Варианты полипептида гамма-интерферона
AU782635B2 (en) Interferon gamma conjugates
AU2002252971A1 (en) Interferon gamma polypeptide variants
ZA200308376B (en) Interferon gamma polypeptide variants.
CZ20033016A3 (cs) Varianty polpeptidu interferonu gamma
AU2002235727A1 (en) New interferon beta-like molecules

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued